Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Metabolic health directly influences reproductive function, with obesity linked to reduced ovulation rates and lower pregnancy success. Recent clinical data shows GLP-1 receptor agonists improve insulin sensitivity and hormone balance—two critical factors for fertility. PlexusDx offers personalized GLP-1 therapy to support women preparing for pregnancy.
How Weight and Metabolism Impact Female Fertility
Excess adipose tissue disrupts the delicate hormonal signals that regulate the menstrual cycle and egg development. High insulin levels trigger elevated androgen production, which can suppress ovulation and cause irregular periods. Inflammation from obesity also reduces egg quality and increases miscarriage risk, independent of age. Studies show that losing just 5–10% of body weight can restore normal ovulation in women with obesity-related infertility.
Metabolic dysfunction—not weight alone—drives many fertility problems. Women with insulin resistance often experience polycystic ovary syndrome (PCOS) symptoms, including anovulation and reduced progesterone. Restoring insulin sensitivity through medical weight loss addresses the root cause rather than treating symptoms. Pre-conception weight optimization improves not only conception rates but also pregnancy outcomes and gestational health.
GLP-1 Receptor Agonists and Reproductive Health
GLP-1 medications work by enhancing insulin secretion, slowing gastric emptying, and activating satiety centers in the brain. These actions reduce appetite, lower blood sugar, and improve insulin sensitivity—all mechanisms that restore normal hormone signaling in the reproductive system. Clinical evidence indicates that women using GLP-1 therapy experience improved menstrual regularity and ovulation resumption within 3–6 months of treatment. The metabolic benefits extend beyond weight loss to systemic inflammation reduction, which further supports egg quality.
Semaglutide, a long-acting GLP-1 agonist, has demonstrated superior insulin sensitivity gains compared to lifestyle intervention alone. Research in women with PCOS shows that GLP-1 therapy improves androgen levels, LH/FSH ratios, and ovulatory function. Unlike some weight-loss approaches that require extreme calorie restriction (which can impair reproductive hormones), GLP-1 therapy maintains hormonal balance while supporting sustainable fat loss. These properties make GLP-1 an ideal option for fertility-focused weight management.
PlexusDx Semaglutide for Pre-Pregnancy Metabolic Optimization
PlexusDx compounds semaglutide injection in licensed 503A pharmacies, ensuring pharmaceutical-grade purity and consistency. Treatment starts at $149 per month with no insurance required, making personalized fertility support accessible. Semaglutide from PlexusDx is HSA/FSA eligible, reducing out-of-pocket costs for eligible patients. The flat monthly pricing structure means your dose can increase as needed without additional cost—addressing the clinical reality that metabolic response varies by individual.
PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after the first month), which maps 14 metabolic pathways and identifies genetic variants affecting GLP-1 response and weight loss potential. Understanding your genetic predispositions—such as FTO rs9939609 (appetite regulation) and GLP1R rs6923761 (GLP-1 receptor sensitivity)—enables true personalization. Women with specific genetic profiles may benefit from dose adjustments or alternative compounds like tirzepatide, optimizing outcomes before conception.
Timeline for Fertility Improvement and Conception Planning
Metabolic improvements from GLP-1 therapy typically emerge within 4–8 weeks, with ovulation resumption often observed by 12 weeks in women with PCOS or obesity-related anovulation. Most fertility specialists recommend 6 months of optimized metabolic health before attempting conception, allowing adequate time for egg maturation and hormonal stabilization. Weight loss during GLP-1 therapy is generally 10–15% of baseline body weight within 6 months—a range consistently associated with restored fertility. Planning your pre-conception timeline with your OB/GYN or fertility specialist ensures GLP-1 therapy aligns with your conception goals.
Once you achieve your target weight and metabolic markers normalize, conception can be attempted while tapering or maintaining GLP-1 therapy in consultation with your healthcare provider. Many women find that sustained metabolic improvements persist even after stopping treatment, supporting long-term reproductive health. Early pregnancy monitoring is important, as with any medication adjustment. PlexusDx's telemedicine model allows seamless coordination with your fertility team throughout this process.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is semaglutide safe if I want to become pregnant?
Current data suggests GLP-1 medications can be safely discontinued 2–3 months before conception attempts. Metabolic benefits—improved insulin sensitivity and hormone balance—typically persist after treatment stops. Always discuss your conception timeline with your OB/GYN before starting or stopping any medication. PlexusDx providers work with your fertility team to coordinate safe, evidence-based pre-conception planning.
How much weight loss is needed to restore ovulation?
Studies show that 5–10% weight loss often restores ovulation in women with obesity-related infertility, while 10–15% loss provides more robust hormonal improvements. GLP-1 therapy typically achieves 10–15% weight loss within 6 months. Individual results vary based on baseline weight, metabolism, and genetic factors—which is why PlexusDx offers the Precision Peptide Genetic Test to predict your personal response.
Does PlexusDx serve patients in all states without insurance?
Yes, PlexusDx serves all 50 states with no insurance requirement or membership fee. Semaglutide injection starts at $149 per month and is HSA/FSA eligible. Your dose may increase as needed, but your monthly price remains flat—ensuring affordability throughout your fertility-focused treatment.
Can GLP-1 therapy help with PCOS-related infertility?
Yes, GLP-1 medications improve insulin sensitivity and lower androgens in PCOS, restoring ovulation in many cases. Clinical trials show improved LH/FSH ratios and menstrual regularity within 3–6 months. PlexusDx's Precision Peptide Genetic Test can identify GIPR and GLP1R variants that predict your individual PCOS response to therapy.
What is the Precision Peptide Genetic Test and how does it help with fertility?
The Precision Peptide Genetic Test ($99) analyzes 150+ genetic insights across 14 metabolic pathways, including variants like FTO rs9939609 and GLP1R rs6923761 that affect appetite, weight loss, and reproductive hormone response. Understanding your genetic predispositions allows PlexusDx to personalize your GLP-1 choice and dosing for optimal fertility outcomes.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Time of Day to Inject Tirzepatide: A Comprehensive Guide
What Are Natural GLP-1 and How Can They Impact Your Health?